Startseite Medizin Efficacy of a strategy to prevent neonatal early-onset group B streptococcal (GBS) sepsis
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Efficacy of a strategy to prevent neonatal early-onset group B streptococcal (GBS) sepsis

  • Regina M. Renner , A. Renner , Seraina Schmid , Irene Hoesli , Per Nars , Wolfgang Holzgreve und Daniel V. Surbek
Veröffentlicht/Copyright: 11. Januar 2006

Abstract

Background: Existing guidelines recommend different strategies to prevent early-onset neonatal GBS sepsis. In 1997, using our own data on incidence and risk factors, we established a new prevention strategy which includes GBS screening at 36 weeks' gestation and intrapartum antibiotic prophylaxis (IAP) in women with positive or unknown GBS colonization with at least one risk factor. The present study evaluates the efficacy of the new prevention strategy.

Methods: Retrospective study of the incidence of early-onset GBS sepsis among all live births at the University Women's Hospital Basel between 1997 and 2002. Additional analysis of delivery and post partum period of all GBS sepsis cases, including GBS screening, risk factors during labor (prematurity, rupture of membranes (ROM) <12 h, intrapartum signs of infection), and IAP. Comparison of this group's characteristics G2 (9,385 live births, using the new strategy) with the previous group, G1 (1984–1993, 16,126 live births, without GBS screening or routine IAP) was performed.

Results: The incidence of early-onset GBS sepsis was reduced from 1/1000 (G1) to 0.53/1000 (G2). We observed a significant reduction of overall intrapartum riskfactors in cases of GBS sepsis.

Conclusion: This study suggests that our new prevention strategy is effective in reducing the incidence of early-onset GBS sepsis in neonates. In comparison, implementation of the CDC's prevention strategy might have prevented 2 additional cases in 9385 live births. However, this would have required treating a much larger number of pregnant women with IAP with consequential increasing costs, side effects and complications.

:

Corresponding author: Dr. Daniel V. Surbek Department of Obstetrics and Gynecology University Hospital Berne Effingerstrasse 102 3010 Berne/Switzerland

References

1 American College of Obstetricians and G: ACOG Committee Opinion: number 279, December 2002. Prevention of early-onset group B streptococcal disease in newborns. [see comment]. Obstet & Gynecol 100 (2002) 1405Suche in Google Scholar

2 Anonymous: Prevention of perinatal group B streptococcal disease: a public health perspective. Centers for Disease Control and Prevention. [erratum appears in MMWR Morb Mortal Wkly Rep 1996 Aug 9;45(31):679]. Morbidity & Mortality Weekly Report Recommendations & Reports 45 (1996) 1Suche in Google Scholar

3 Anonymous: From the Centers for Disease Control. Revision of guidelines for the prevention of perinatal group B streptococcal disease. J Am Med Assoc 287 (2002) 1106Suche in Google Scholar

4 Anonymous: ACNM Clinical Bullletin. Early-onset group B strep infection in newborns: Prevention and prophylaxis number 2, April 2003. J Midwifery & Women's Health 48 (2003) 375Suche in Google Scholar

5 Boyer KM, SP Gotoff: Prevention of early-onset neonatal group B streptococcal disease with selective intrapartum chemoprophylaxis. New England J Med314 (1986) 1665Suche in Google Scholar

6 Centers for Disease Control and P: Diminishing racial disparities in early-onset neonatal group B streptococcal disease – United States, 2000–2003. MMWR Morbidity & Mortality Weekly Report 53 (2004) 502Suche in Google Scholar

7 DGGG. Empfehlungen zur Prophylaxe der Neugeborenensepsis (fruehe Form) durch Streptokokken der Gruppe B. (2004). http://www.dggg.de/leitlinien/pdf/4-3-4.pdfSuche in Google Scholar

8 Epi Info™. 2004; Centers for Disease Control and Prevention (CDC)Suche in Google Scholar

9 Gibbs RS, S Schrag, A Schuchat: Perinatal infections due to group B streptococci. Obstet & Gynecol104 (2004) 1062Suche in Google Scholar

10 Gilbert R: Prenatal screening for group B streptococcal infection: gaps in the evidence. Int J Epidemiol33 (2003) 210.1093/ije/dyh062Suche in Google Scholar

11 Hickman ME, MA Rench, P Ferrieri, CJ Baker: Changing epidemiology of group B streptococcal colonization. Pediatrics104 (1999) 203Suche in Google Scholar

12 Jolivet RR, P Centers for Disease Control and: Early-onset neonatal group B streptococcal infection: 2002 guidelines for prevention. J Midwifery & Women's Health47 (2002) 435Suche in Google Scholar

13 McCracken G: Group B streptococci: the new challenge in neonatal infections. J Pediatr82 (1973) 70310.1016/S0022-3476(73)80603-1Suche in Google Scholar

14 Mohle-Boetani JC, A Schuchat, BD Plikaytis, JD Smith, CV Broome: Comparison of prevention strategies for neonatal group B streptococcal infection. A population-based economic analysis. J Am Med Assoc270 (1993) 1442Suche in Google Scholar

15 NCCLS: Manual of Clinical Microbiology. (2005)Suche in Google Scholar

16 Puopolo KM, LC Madoff, EC Eichenwald: Early-Onset Group B Streptococcal Disease in the Era of Maternal Screening. Pediatrics115 (2005) 1240Suche in Google Scholar

17 Rouse DJ, RL Goldenberg, SP Cliver, GR Cutter, ST Mennemeyer, CA Fargason, Jr: Strategies for the prevention of early-onset neonatal group B streptococcal sepsis: a decision analysis. Obstet & Gynecol83 (1994) 483Suche in Google Scholar

18 Schrag S, R Gorwitz, K Fultz-Butts, A Schuchat: Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC. Morbidity & Mortality Weekly Report. Recommendations & Reports51 (2002) 1Suche in Google Scholar

19 Schrag SJ, ER Zell, R Lynfield, A Roome, KE Arnold, AS Craig, LH Harrison, A Reingold, K Stefonek, G Smith, M Gamble, A Schuchat, T Active Bacterial Core Surveillance: A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates. [see comment]. New England J Med347 (2002) 233Suche in Google Scholar

20 Schrag SJ, S Zywicki, MM Farley, AL Reingold, LH Harrison, LB Lefkowitz, JL Hadler, R Danila, PR Cieslak, A Schuchat: Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. [see comment]. New England J Med342 (2000) 15Suche in Google Scholar

21 Schuchat A: Impact of intrapartum chemoprophylaxis on neonatal sepsis. Pediat Infect Disease J22 (2003) 108710.1097/01.inf.0000104181.42070.9fSuche in Google Scholar PubMed

22 Smaill F: Intrapartum antibiotics for group B streptococcal colonisation. Cochrane Database of Systematic Reviews (2000) CD000115Suche in Google Scholar

23 Stan CM, M Boulvain, PA Bovier, R Auckenthaler, M Berner, O Irion: Choosing a strategy to prevent neonatal early-onset group B streptococcal sepsis: economic evaluation. BJOG: and Internat J Obstet & Gynaecol108 (2001) 840Suche in Google Scholar

24 Surbek DS, J Pavic, N Almendral, AC: Neonatale Streptokokken-B Sepsis: Izidenz und Riskofaktoren. Arch Gynecol Obstet257 (1995) 148Suche in Google Scholar

25 Trijbels-Smeulders MA, LA Kollee, AH Adriaanse, JL Kimpen, LJ Gerards: Neonatal group B streptococcal infection: incidence and strategies for prevention in Europe. [see comment]. Pediat Infect Disease J23 (2004) 172Suche in Google Scholar

26 Yancey MK, A Schuchat, LK Brown, VL Ventura, GR Markenson: The accuracy of late antenatal screening cultures in predicting genital group B streptococcal colonization at delivery. Obstet & Gynecol88 (1996) 811Suche in Google Scholar

Published Online: 2006-01-11
Published in Print: 2006-02-01

©2006 by Walter de Gruyter Berlin New York

Heruntergeladen am 31.12.2025 von https://www.degruyterbrill.com/document/doi/10.1515/JPM.2006.005/html
Button zum nach oben scrollen